Skip to search.
 BSE Up 0.64% NSE Up 0.38%

More On AEZS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Aeterna Zentaris Inc. (AEZS)

-NasdaqCM
3.27 Down 0.20(5.76%) 1:30am
Prev Close:3.47
Open:3.48
Bid:3.30 x 100
Ask:8.00 x 100
1y Target Est:11.63
Beta:0.759287
Next Earnings Date:N/A
Day's Range:3.24 - 3.51
52wk Range:2.60 - 53.00
Volume:278,913
Avg Vol (3m):294,285
Market Cap:20.69M
P/E (ttm):N/A
EPS (ttm):-30.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for AEZS at this time.

Comparison

Symbol% ChgMkt Cap
AEZSDown 5.76%20.69M
CELGUp 0.80%78.78B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):48.36
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-3.12
Quarterly EPS Est (Mar-16) :-0.74
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback